AR088234A1 - COMPOSITION FOR USE IN THE NAILS IN A HUMAN PATIENT - Google Patents
COMPOSITION FOR USE IN THE NAILS IN A HUMAN PATIENTInfo
- Publication number
- AR088234A1 AR088234A1 ARP120103701A ARP120103701A AR088234A1 AR 088234 A1 AR088234 A1 AR 088234A1 AR P120103701 A ARP120103701 A AR P120103701A AR P120103701 A ARP120103701 A AR P120103701A AR 088234 A1 AR088234 A1 AR 088234A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- nails
- nail
- deficiency
- immunomodulator
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Composición para uso en las uñas en un paciente humano, que contiene un inmunomodulador, donde la composición está en una emulsión aceite-en-agua y se aplica tópicamente a las uñas del paciente. Reivindicación 1: Una composición para uso en la mejora de la salud de las uñas en un paciente humano, la composición que contiene un inmunomodulador en el que la composición está en una emulsión aceite-en- agua, y se aplica tópicamente a las uñas del paciente. Reivindicación 2: La composición de la reivindicación 1, en la que el inmunomodulador es la ciclosporina. Reivindicación 4: La composición de la reivindicación 3, en la que el anti-inflamatorio es quetorolac. Reivindicación 5: La composición de la reivindicación 1, en la que la emulsión contiene aceite de ricino y un tensioactivo. Reivindicación 6: La composición de la reivindicación 1, en la que la emulsión contiene, por lo menos, un componente seleccionado del grupo que consiste en glicerina, polisorbato 80 y carbómero. Reivindicación 7: La composición de la reivindicación 1, en la que la composición contiene 0,5% - 1,5% p/p de polisorbato 80, 0,5% - 1,5% p/p de glicerina, 0,5% -1,5% p/p de aceite de ricino, 0,05% - 0,1% p/p carbómero 1342 y manitol. Reivindicación 11: La composición de la reivindicación 1, que es útil para tratar un trastorno de la uña seleccionado del grupo que consiste de psoriasis ungueal, distrofia ungueal psoriásica, síndrome de las uñas quebradizas, incremento de la longitud y grosor de las uñas, oniquia, oniquiagriposis, oniquia trofia, onicocriptosis, onicodistrofia, onicogriposis, onicolisis, onicomadesis, onicauxis, onicomicosis, onicorrexis, tinea unguium, onicofosis, onicoptosis, paroniquia, pseudomonas, pterigián y unguis inversa pterigián, coiloniquia, hematoma subungueal, o algún otro trauma en la uña, deficiencia del ácido fólico, leuconiquia, síndrome de la patela de las uñas, melanoniquia, deficiencia de proteínas, uñas quebradizas y descamadas, uñas dañadas por metacrilato, deficiencia de la vitamina C, deficiencia de la vitamina, unguis tinea, adelgazamiento de las uñas asociada al liquen plano, enfermedad de Raynaud, sangrado asociado con la artritis reumatoide, líneas de beau, y líneas de Mee asociadas con ciertos tipos de envenenamiento.Composition for use on the nails in a human patient, which contains an immunomodulator, where the composition is in an oil-in-water emulsion and is applied topically to the patient's nails. Claim 1: A composition for use in improving the health of the nails in a human patient, the composition containing an immunomodulator in which the composition is in an oil-in-water emulsion, and is applied topically to the nails of the patient. Claim 2: The composition of claim 1, wherein the immunomodulator is cyclosporine. Claim 4: The composition of claim 3, wherein the anti-inflammatory is ketorolac. Claim 5: The composition of claim 1, wherein the emulsion contains castor oil and a surfactant. Claim 6: The composition of claim 1, wherein the emulsion contains at least one component selected from the group consisting of glycerin, polysorbate 80 and carbomer. Claim 7: The composition of claim 1, wherein the composition contains 0.5% - 1.5% w / w polysorbate 80, 0.5% - 1.5% w / w glycerin, 0.5 % -1.5% w / w castor oil, 0.05% - 0.1% w / w carbomer 1342 and mannitol. Claim 11: The composition of claim 1, which is useful for treating a nail disorder selected from the group consisting of nail psoriasis, psoriatic nail dystrophy, brittle nail syndrome, increased nail length and thickness, onychia , onychiagriposis, onychia trophy, onicocriptosis, onychodystrophy, onychromyposis, onycholysis, onychomadesis, onicauxis, onychomycosis, onychorrhexis, tinea unguium, onychophoresis, onicoptosis, paronychia, pseudomonas, pterygian or othergia, subcutaneous or other trauma in a hematomae nail, folic acid deficiency, leuconychia, nail patella syndrome, melanonychia, protein deficiency, brittle and peeling nails, methacrylate damaged nails, vitamin C deficiency, vitamin deficiency, tinea unguis, thinning of the nails associated with lichen planus, Raynaud's disease, bleeding associated with rheumatoid arthritis, d lines e beau, and Mee lines associated with certain types of poisoning.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161543758P | 2011-10-05 | 2011-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR088234A1 true AR088234A1 (en) | 2014-05-21 |
Family
ID=47046873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120103701A AR088234A1 (en) | 2011-10-05 | 2012-10-04 | COMPOSITION FOR USE IN THE NAILS IN A HUMAN PATIENT |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2763649A2 (en) |
JP (1) | JP2014528447A (en) |
KR (1) | KR20140096048A (en) |
CN (1) | CN103987370A (en) |
AR (1) | AR088234A1 (en) |
AU (1) | AU2012318823A1 (en) |
BR (1) | BR112014008172A2 (en) |
CA (1) | CA2851346A1 (en) |
TW (1) | TW201321025A (en) |
WO (1) | WO2013052424A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013181339A2 (en) | 2012-06-01 | 2013-12-05 | Allergan, Inc. | Cyclosporin a analogs |
WO2016112321A1 (en) | 2015-01-08 | 2016-07-14 | Allergan, Inc. | Cyclosporin derivatives wherein the mebmt sidechain has been cyclized |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2907460A1 (en) | 1978-03-07 | 1979-09-13 | Sandoz Ag | NEW RESORBABLE GALENIC COMPOSITIONS |
US5342625A (en) | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
DK1163254T3 (en) | 1999-02-26 | 2008-06-09 | Univ British Columbia | TRPM-2 antisense treatment |
US6254860B1 (en) | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
US20060008432A1 (en) * | 2004-07-07 | 2006-01-12 | Sebastiano Scarampi | Gilsonite derived pharmaceutical delivery compositions and methods: nail applications |
US7288520B2 (en) * | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
EP1958638A1 (en) * | 2007-02-14 | 2008-08-20 | Polichem S.A. | Use of chitosans to increase nail growth rate |
CN102271700A (en) * | 2009-01-08 | 2011-12-07 | 阿勒根公司 | Cyclosporine compositions for enhancing nail growth |
-
2012
- 2012-10-01 EP EP12775399.4A patent/EP2763649A2/en not_active Withdrawn
- 2012-10-01 WO PCT/US2012/058333 patent/WO2013052424A2/en active Application Filing
- 2012-10-01 CN CN201280059691.1A patent/CN103987370A/en active Pending
- 2012-10-01 KR KR1020147011967A patent/KR20140096048A/en not_active Application Discontinuation
- 2012-10-01 BR BR112014008172A patent/BR112014008172A2/en not_active IP Right Cessation
- 2012-10-01 CA CA2851346A patent/CA2851346A1/en not_active Abandoned
- 2012-10-01 JP JP2014534627A patent/JP2014528447A/en active Pending
- 2012-10-01 AU AU2012318823A patent/AU2012318823A1/en not_active Abandoned
- 2012-10-04 AR ARP120103701A patent/AR088234A1/en not_active Application Discontinuation
- 2012-10-05 TW TW101137027A patent/TW201321025A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2851346A1 (en) | 2013-04-11 |
TW201321025A (en) | 2013-06-01 |
AU2012318823A1 (en) | 2014-04-24 |
KR20140096048A (en) | 2014-08-04 |
EP2763649A2 (en) | 2014-08-13 |
JP2014528447A (en) | 2014-10-27 |
WO2013052424A3 (en) | 2013-11-14 |
WO2013052424A2 (en) | 2013-04-11 |
BR112014008172A2 (en) | 2017-04-18 |
CN103987370A (en) | 2014-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI202100009A (en) | METHODS TO REDUCE THE NEED FOR REVASCU | |
BR112015032336A2 (en) | personal care articles | |
CY1121398T1 (en) | COMBINATION OF BREAKFAST AND BENZOLE PEROXIDE FOR THE TREATMENT OF ACNE DAMAGES | |
EP2005941A3 (en) | Cellular rejuvenation compounds | |
ECSP13012546A (en) | TOPICAL FORMULATION FOR A JAK INHIBITOR | |
BR112012029812A2 (en) | cosmetic composition based on a supramolecular polymer and an absorbent filler | |
BRPI0700148A (en) | low viscosity, long-lasting, cold preparation cosmetic emulsions | |
CO6460708A2 (en) | BORINIC COMPOSITIONS | |
CO6231001A2 (en) | STABILIZATION OF VITAMIN B12 | |
BRPI1010369B8 (en) | oil-in-water nanoemulsion cosmetic composition and use of a | |
BR112015005369A2 (en) | usp30 inhibitors and methods for their use | |
CR20110219A (en) | NAPHYLACTIC ACIDS | |
BR112014012726A2 (en) | hair care compositions | |
BR112015019395A2 (en) | compositions and methods for treating and repairing tendons | |
AR088234A1 (en) | COMPOSITION FOR USE IN THE NAILS IN A HUMAN PATIENT | |
AR074765A1 (en) | ENAMEL OF ONE THAT INCLUDES A DRYING OIL, A FILM FORMING POLYMER, AND A METAL SALT, AND MAKEUP PRODUCT | |
ES2497667T3 (en) | Emulsification system for use in cosmetics | |
AR085048A1 (en) | IMPROVED MOISTURIZING COMBINATION | |
AR109799A1 (en) | COMPOSITION FOR HAIR TREATMENT | |
BRPI0706244A2 (en) | cosmetic compositions, use of at least one ester and cosmetic process for the makeup and / or care of keratin skin, lips and / or fibers | |
ECSP15050273A (en) | ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | |
AR097216A1 (en) | COMPOSITION FOR TREATMENT AGAINST SKIN AGING | |
EP2223679A3 (en) | Cellular rejuvenation compounds | |
AR056018A1 (en) | A COMPOSITION TO USE ON THE SKIN | |
BR112014015147A2 (en) | dianidrohexitol diester mixture gc |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |